KYTX ▼ -5.1% - Kyverna Therapeutics, Inc. $KYTX - Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026 23-OCT-2026 10:30 AM ET